Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-001636
Filing Date
2017-10-06
Accepted
2017-10-06 18:20:50
Documents
1
Period of Report
2017-10-04

Document Format Files

Seq Description Document Type Size
1 form4-10062017_031038.html 4  
1 form4-10062017_031038.xml 4 22451
  Complete submission text file 0001415889-17-001636.txt   23803
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3911 SORRENTO VALLEY BLVD. SAN DIEGO CA 92121
Business Address
Baity Glenn (Reporting) CIK: 0001487100 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 171128309